CA20532-3 - 0x00000000000030CF

Study Number: CA20532
Group Number: 3
Study Requirement: Asthmatic
Stipend: up to £ 2,070

Study Criteria:

  • Age: 18 - 60
  • BMI: 18 - 32
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat asthma.
  • Route of Administration: Inhalation; Injection subcutaneous
  • Blood Draws: 11

Study Schedule:

  • Schedule Type: Return Only
  • Study Length: 11 Returns

Screening Dates:

Event Day Event Date Site
Thursday Oct 26 2017 Belfast

Doctor Exam Dates:

Event Day Event Date Site
Tuesday Oct 24 2017 Belfast
Thursday Oct 26 2017 Belfast

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Return Friday Nov 10 2017 6:30AM Friday Nov 10 2017 5:30PM 1 Belfast
Return Friday Nov 17 2017 6:30AM Friday Nov 17 2017 11:30AM 1 Belfast
Return Friday Nov 24 2017 6:30AM Friday Nov 24 2017 11:30AM 1 Belfast
Return Friday Dec 1 2017 6:30AM Friday Dec 1 2017 11:30AM 1 Belfast
Return Friday Dec 8 2017 6:30AM Friday Dec 8 2017 9:30AM 1 Belfast
Return Friday Jan 5 2018 6:30AM Friday Jan 5 2018 9:30AM 1 Belfast
Return Friday Feb 2 2018 6:30AM Friday Feb 2 2018 9:30AM 1 Belfast
Return Friday Mar 2 2018 6:30AM Friday Mar 2 2018 9:30AM 1 Belfast
Return Friday Mar 30 2018 6:30AM Friday Mar 30 2018 9:30AM 1 Belfast
Return Friday May 25 2018 6:30AM Friday May 25 2018 9:30AM 1 Belfast
Return Tuesday Jul 17 2018 6:30AM Tuesday Jul 17 2018 9:30AM 1 Belfast